mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-05 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0001 |